Multiple Sclerosis

The NeurologyLive® MS Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with multiple sclerosis and demyelinating disorders.

Latest News

Advancing MS Research Through Recognition and Innovation: The John Dystel Prize
Advancing MS Research Through Recognition and Innovation: The John Dystel Prize

April 28th 2025

Bruce Bebo, PhD, and Amit Bar-Or, MD, FRCPC, FAAN, FANA, discussed the impact of the John Dystel Prize on multiple sclerosis research and its role in shaping future clinical advancements.

Fish Consumption Leads to Better Disability Progression in Multiple Sclerosis
Fish Consumption Leads to Better Disability Progression in Multiple Sclerosis

April 26th 2025

UMass Commences Dosing for Ongoing Phase 2 Trial of CAR T-Cell Therapy in Nonactive Secondary Progressive MS
UMass Commences Dosing for Ongoing Phase 2 Trial of CAR T-Cell Therapy in Nonactive Secondary Progressive MS

April 25th 2025

Two-Year Open-Label Data Highlight Frexalimab’s Impact on Disease Activity in Relapsing Multiple Sclerosis
Two-Year Open-Label Data Highlight Frexalimab’s Impact on Disease Activity in Relapsing Multiple Sclerosis

April 5th 2025

Levi Garraway, MD, PhD  (Credit: LinkedIn)
Genentech Reports High-Dose Ocrelizumab Fails to Show Additional Benefit in Relapsing MS

April 2nd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.